---
title: Repurposing an endogenous degradation domain for antibody-mediated disposal
  of cell-surface proteins
date: '2024-01-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38287192/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240130170654&v=2.18.0
source: heidelberg[Affiliation]
description: The exquisite specificity of antibodies can be harnessed to effect targeted
  degradation of membrane proteins. Here, we demonstrate targeted protein removal
  utilising a protein degradation domain derived from the endogenous human protein
  Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9). Recombinant antibodies genetically
  fused to this domain drive the degradation of membrane proteins that undergo constitutive
  internalisation and recycling, including the transferrin receptor and the ...
disable_comments: true
---
The exquisite specificity of antibodies can be harnessed to effect targeted degradation of membrane proteins. Here, we demonstrate targeted protein removal utilising a protein degradation domain derived from the endogenous human protein Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9). Recombinant antibodies genetically fused to this domain drive the degradation of membrane proteins that undergo constitutive internalisation and recycling, including the transferrin receptor and the ...